Skip to main content
Log in

Solubility enhancement of ibuprofen using tri-ureasil-PPO hybrid: structural, cytotoxic, and drug release investigation

  • Original Paper
  • Published:
Journal of Sol-Gel Science and Technology Aims and scope Submit manuscript

Abstract

Herein, we used tri-ureasil organic–inorganic hybrid material (tU5000) in order to enhance the solubility of nonsteroidal anti-inflammatory drugs and fine tuning the drug delivery profile. For the first time, we used tU5000 as a film-forming agent in order to provide an alternative vehicle for transdermal drug delivery systems which the cell viability of practically 100 % for the highest and the lowest tested concentrations of pure tU5000 indicated that the material was not cytotoxic. The physicochemical properties of the tU5000 drug carrier and drug-loaded hybrids were systematically studied using powder X-ray diffraction, differential scanning calorimetry, small-angle X-ray scattering, and Fourier-transform infrared spectroscopy. The structural changes of tU5000 as well as the relationships between the drug content and in vitro drug release behaviors were investigated. The results showed that the ibu molecules were homogeneously distributed in the tU5000 xerogels contributing to fine-tuning the drug delivery profile. Considering the ability to incorporated high drug content, simple and mild preparation procedure by one-pot sol–gel route, high stability of the materials, sustained-release property, this class of hybrid based on polymers and inorganic compounds may have potential applications in the design of pharmaceutical formulation as ophthalmic (contact lenses), transdermal (patches) and implantable (soft tissue) drug delivery systems.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Scheme 1
Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Sanchez C, Belleville P, Popall M, Nicole L (2011) Applications of advanced hybrid organic–inorganic nanomaterials: from laboratory to market. Chem Soc Rev 40:696–753

    Article  Google Scholar 

  2. Sanchez C, Julian B, Belleville P, Popall M (2005) Applications of hybrid organic–inorganic nanocomposites. J Mater Chem 15:3559–3592

    Article  Google Scholar 

  3. Sanchez C, Soler-Illia GJAA, Ribot F, Lalot T, Mayer CR, Cabuil V (2001) Designed hybrid organic-inorganic nanocomposites from functional nanobuilding blocks. Chem Mater 13:3061–3083

    Article  Google Scholar 

  4. Kickelbick G (2006) Hybrid materials. Wiley-VCH, Weinheim

    Book  Google Scholar 

  5. Soler-Illia GJAA, Azzaroni O (2011) Multifunctional hybrids by combining ordered mesoporous materials and macromolecular building blocks. Chem Soc Rev 40:1107–1150

    Article  Google Scholar 

  6. Mehdi A, Reye C, Corriu RJP (2011) From molecular chemistry to hybrid nanomaterials. Design and functionalization. Chem Soc Rev 40:563–574

    Article  Google Scholar 

  7. Harrisson S, Nicolas J, Maksimenko A, Bui DT, Mougin J, Couvreur P (2013) Nanoparticles with in vivo anticancer activity from polymer prodrug amphiphiles prepared by living radical polymerization. Angew Chem Int Ed 52:1678–1682

    Article  Google Scholar 

  8. Ge Z, Liu S (2013) Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance. Chem Soc Rev 42:7289–7325

    Article  Google Scholar 

  9. Laine L, Smith R, Min K, Chen C, Dubois RW (2006) Systematic review: the lower gastrointestinal adverse effects of non-steroidal antiinflammatory drugs. Aliment Pharmacol Ther 24:751–767

    Article  Google Scholar 

  10. Narayanan D, Geena MG, Lakshmi H, Koyakutty M, Nair S, Menon D (2013) Poly-(ethylene glycol) modified gelatin nanoparticles for sustained delivery of the anti-inflammatory drug ibuprofen-sodium: an in vitro and in vivo analysis. Nanomedicine 9:818–828

    Article  Google Scholar 

  11. Crielaard BJ, Lammers T, Schiffelers RM, Storm GJ (2012) Drug targeting systems for inflammatory disease: one for all, all for one. J Control Release 161:225–234

    Article  Google Scholar 

  12. Rosario-Meléndez R, Yu W, Uhrich KE (2013) Biodegradable polyesters containing ibuprofen and naproxen as pendant groups. Biomacromolecules 14:3542–3548

    Article  Google Scholar 

  13. Gao Q, Xu Y, Wu D, Shen W, Deng F (2010) Synthesis. Characterization, and in Vitro pH-controllable drug release from mesoporous silica spheres with switchable gates langmuir 26:17133–17138

    Google Scholar 

  14. Yu D, Williams GR, Yang J, Wang X, Yang J, Li X (2011) Solid lipid nanoparticles self-assembled from electrosprayed polymer-based microparticles. J Mater Chem 21:15957–15961

    Article  Google Scholar 

  15. Lamprecht A, Saumet J, Roux J, Benoit J (2004) Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment. Int J Pharm 278:407–414

    Article  Google Scholar 

  16. Jia H, Kerr LL (2013) Sustained ibuprofen release using composite poly(lactic-co-glycolic acid)/titanium dioxide nanotubes from Ti implant surface. J Pharm Sci 102:2341–2348

    Article  Google Scholar 

  17. Mirzaagha B (2008) Design, synthesis and in vitro evaluation of vinyl ether type polymeric prodrugs of ibuprofen, ketoprofen and naproxen. Int J Pharm 356:167–173

    Article  Google Scholar 

  18. Yang P, Gai S, Lin J (2012) Functionalized mesoporous silica materials for controlled drug delivery. Chem Soc Rev 41:3679–3698

    Article  Google Scholar 

  19. Vallet-Regi M, Colilla M, Gonzalez B (2001) Medical applications of organic–inorganic hybrid materials within the field of silica-based bioceramics. Chem Soc Rev 40:596–607

    Article  Google Scholar 

  20. Zhu Y, Shi J, Shen W, Dong X, Feng J, Ruan M, Li Y (2005) Stimuli-responsive controlled drug release from a hollow mesoporous silica sphere/polyelectrolyte multilayer core-shell structure. Angew Chem Int Ed 44:5083–5087

    Article  Google Scholar 

  21. Balas F, Manzano M, Horcajada P, Vallet-Regi M (2006) Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials. J Am Chem Soc 128:8116–8117

    Article  Google Scholar 

  22. Vallet-Regi M (2006) Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering. Chem Eur J 12:5934–5943

    Article  Google Scholar 

  23. Makiko F, Naohide H, Kumi S (2000) Effect of fatty acid Esters on permeation of ketoprofen through hairless rat skin. Int J Pharm 205:117–125

    Article  Google Scholar 

  24. Vergote GJ, Vervaet C, Driessche IV (2001) An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen. Int J Pharm 219:81–87

    Article  Google Scholar 

  25. Perioli L, Ambrogi V, Bernardini C (2004) Potential prodrugs of non-steroidal anti-inflammatory agents for targeted drug delivery to the CNS. Eur J Med Chem 39:715–727

    Article  Google Scholar 

  26. Chie K, Kenji K, Kazuo M (2009) Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs. Bioconjug Chem 11:910–917

    Google Scholar 

  27. Koç FE, Senel M (2013) Solubility enhancement of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) using polypolypropylene oxide core PAMAM dendrimers. Int J Pharm 451:18–22

    Article  Google Scholar 

  28. Molina EF, Marçal L, Carvalho HWP, Nassar EJ, Ciuffi KJ (2013) Tri-ureasil gel as a multifunctional organic–inorganic hybrid matrix. Polym Chem 4:1575–1582

    Article  Google Scholar 

  29. Nolasco MM, Vaz PM, Freitas VT, Lima PP, Andre PS, Ferreira RAS, Vaz PD, Ribeiro-Claro P, Carlos LD (2013) Engineering highly efficient Eu(III)-based tri-ureasil hybrids toward luminescent solar concentrators. J Mater Chem A 1:7339–7350

    Article  Google Scholar 

  30. Berridge MV, Herst PM, Tan AS (2005) Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol Annu Rev 11:127–152

    Article  Google Scholar 

  31. Bernas T, Dobrucki J (1999) Reduction of a tetrazolium salt, CTC, by intact HepG2 human hepatoma cells: subcellular localisation of reducing systems. Biochim Biophys Acta 1451:73–81

    Article  Google Scholar 

  32. Chujo Y, Saegusa T (1992) Adv Polym Sci 100:11–13

    Article  Google Scholar 

  33. Freitas VT, Lima PP, Bermudez VZ, Ferreira RAS, Carlos LD (2012) Boosting the emission quantum yield of urea cross-linked tripodal poly(oxypropylene)/siloxane hybrids through the variation of catalyst concentration. Eur J Inorg Chem 32:5390–5395

    Article  Google Scholar 

  34. Newman A, Engers D, Bates S, Ivanisevic I, Kelly RC, Zografi G (2008) Characterization of amorphous API: polymer mixtures using X-ray powder diffraction. J Pharm Sci 97:4840–4856

    Article  Google Scholar 

  35. Mahieu A, Willart J, Dudognon E, Danède F, Descamps MA (2013) New protocol to determine the solubility of drugs into polymer matrixes. Mol Pharm 10:560–566

    Article  Google Scholar 

  36. Kianfar F, Antonijevic MD, Chowdhry BZ, Boateng JS (2011) Formulation development of a carrageenan based delivery system for buccal drug delivery using ibuprofen as a model drug. J Biomater Nanobiotech 2:582–595

    Article  Google Scholar 

  37. Dahmouche K, Santilli CV, Pulcinelli SH, Craievich AF (1999) Small-angle X-ray scattering study of sol–gel-derived siloxane–PEG and siloxane–PPG hybrid materials. J Phys Chem B 103:4937–4942

    Article  Google Scholar 

  38. Freer AA, Bunyan JM, Shankland N, Sheen DB (1993) Structure of (S)-(+)-ibuprofen. Acta Crystallogr Sect C 49:1378–1380

    Article  Google Scholar 

  39. Levin CS, Kundu J, Janesko BG, Scuseria GE, Raphael RM, Halas NJ (2008) Interactions of ibuprofen with hybrid lipid bilayers probed by complementary surface-enhanced vibrational spectroscopies. J Phys Chem B 112:14168–14175

    Article  Google Scholar 

  40. Yoon S, Ichikawa K, MacKnight WJ, Hsu SL (1995) Spectroscopic analysis of chain conformation of poly(propylene oxide)-based polymer electrolytes. Macromolecules 28:4278–4283

    Article  Google Scholar 

  41. Zea Bermudez V, Carlos LD, Alcacer L (1999) Sol–gel derived urea cross-linked organically modified silicates. 1. Room temperature mid-infrared spectra. Chem Mater 11:569–580

    Article  Google Scholar 

  42. Molina EF, Pulcinelli SH, Santilli CV, Briois V (2012) Ligand exchange inducing efficient incorporation of CisPt derivatives into Ureasil–PPO hybrid and their interactions with the multifunctional hybrid network. J Phys Chem B 116:7931–7939

    Article  Google Scholar 

  43. Molina EF, Pulcinelli SH, Santilli CV, Blanchandin S, Briois V (2010) Controlled cisplatin delivery from Ureasil-PEO1900 hybrid matrix. J Phys Chem B 114:3461–3466

    Article  Google Scholar 

  44. Lopes L, Molina EF, Chiavacci LA, Santilli CV, Briois V, Pulcinelli SH (2012) Drug–matrix interaction of sodium diclofenac incorporated into ureasil-poly(ethylene oxide) hybrid materials. RSC Advances 2:5629–5636

    Article  Google Scholar 

  45. Lemaire V (2003) Structural modeling of drug release from biodegradable porous matrices based on a combined diffusion/erosion process. Int J Pharm 258:95–107

    Article  Google Scholar 

  46. Kim S, Ha J, Lee Y (2000) Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide)/poly(ϵ-caprolactone) (PCL) amphiphilic block copolymeric nanospheres: II. Thermo-responsive drug release behaviors. J Control Release 65:345–358

    Article  Google Scholar 

  47. Zuleger S, Lippold BC (2001) Polymer particle erosion controlling drug release. I. Factors influencing drug release and characterization of the release mechanism. Int J Pharm 217:139–152

    Article  Google Scholar 

  48. Siepmann J, Peppas NA (2012) Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliver Rev 64:163–174

    Article  Google Scholar 

  49. Ritger PL, Peppas NA (1987) A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release 5:37–42

    Article  Google Scholar 

  50. Siepmann J, Peppas NA (2001) Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose. Adv Drug Deliver Rev 48:139–157

    Article  Google Scholar 

  51. Yang YQ, Guo XD, Lin WJ, Zhang LJ, Zhang CY, Qian Y (2012) Amphiphilic copolymer brush with random pH-sensitive/hydrophobic structure: synthesis and self-assembled micelles for sustained drug delivery. Soft Matter 8:454–464

    Article  Google Scholar 

Download references

Acknowledgments

The authors would like to thank the financial support received from the Brazilian agencies CAPES, CNPq, and FAPESP (project number 2013/02613-0). We thank the Brazilian Synchrotron Light Laboratory (LNLS) for SAXS measurements and the D01A-SAXS1 beamline staff for all assistance with the X-ray scattering experiments. We would also like to thank Leila A. Chiavacci for allowing us to use their laboratory premises (UNESP/Araraquara) during the UV–vis release experiments.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eduardo F. Molina.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 1,167 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Caravieri, B.B., de Oliveira, P.F., Furtado, R.A. et al. Solubility enhancement of ibuprofen using tri-ureasil-PPO hybrid: structural, cytotoxic, and drug release investigation. J Sol-Gel Sci Technol 72, 627–636 (2014). https://doi.org/10.1007/s10971-014-3485-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10971-014-3485-3

Keywords

Navigation